Skip to main content
. 2023 May 24;13(6):1237. doi: 10.3390/life13061237

Table 3.

JBI critical appraisal of the included case control studies.

Study Lin et al., 2017 [18] Lin et al., 2017 [16] Li et al., 2021 [19] Hou et al., 2022 [17]
Q1 Were the groups comparable other than the presence of disease in cases or the absence of disease in controls? Yes Yes Yes Yes
Q2 Were cases and controls matched appropriately? Yes Yes Yes Yes
Q3 Were the same criteria used for identification of cases and controls? Yes Yes Yes Yes
Q4 Was exposure measured in a standard, valid and reliable way? Yes Yes Yes Yes
Q5 Was exposure measured in the same way for cases and controls? Yes Yes Yes Yes
Q6 Were confounding factors identified? Unsure Unsure Unsure Unsure
Q7 Were strategies to deal with confounding factors stated? Unsure Unsure Unsure Unsure
Q8 Were outcomes assessed in a standard, valid and reliable way for cases and controls? Yes Yes Yes Yes
Q9 Was the exposure period of interest long enough to be meaningful? Yes Yes Yes Yes
Q10 Was appropriate statistical analysis used? Yes Yes Yes Yes
Total Score 80% 80% 80% 80%